ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2009
Tailoring BRCAPRO to Asian-Americans.
Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Simpson's paradox in the integrated discrimination improvement.Statistics in medicine · 2017Article
- A two-stage approach to genetic risk assessment in primary care.Breast cancer research and treatment · 2016Article
- Recent Enhancements to the Genetic Risk Prediction Model BRCAPRO.Cancer informatics · 2015Review
- Recent BRCAPRO upgrades significantly improve calibration.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2014Article
- Reclassification of predictions for uncovering subgroup specific improvement.Statistics in medicine · 2014Article
- Providing access to risk prediction tools via the HL7 XML-formatted risk web service.Breast cancer research and treatment · 2013Article
- Simplifying clinical use of the genetic risk prediction model BRCAPRO.Breast cancer research and treatment · 2013Article
- Hereditary breast cancer in the Han Chinese population.Journal of epidemiology · 2013Review
- The BRCAPRO 5.0 model is a useful tool in genetic counseling and clinical management of male breast cancer cases.European journal of human genetics : EJHG · 2010Article
Corrections and comments
- Comment on
Authors and funding
3 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.